Global Central Nervous System Disease Drugs Market Growth (Status and Outlook) 2026-2032
The global Central Nervous System Disease Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Central Nervous System Disease Drugs Industry Forecast? looks at past sales and reviews total world Central Nervous System Disease Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Central Nervous System Disease Drugs sales for 2026 through 2032. With Central Nervous System Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Central Nervous System Disease Drugs industry.
This Insight Report provides a comprehensive analysis of the global Central Nervous System Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Central Nervous System Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Central Nervous System Disease Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Central Nervous System Disease Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Central Nervous System Disease Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Central Nervous System Disease Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Central Nervous System Disease Drugs Industry Forecast? looks at past sales and reviews total world Central Nervous System Disease Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Central Nervous System Disease Drugs sales for 2026 through 2032. With Central Nervous System Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Central Nervous System Disease Drugs industry.
This Insight Report provides a comprehensive analysis of the global Central Nervous System Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Central Nervous System Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Central Nervous System Disease Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Central Nervous System Disease Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Central Nervous System Disease Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Central Nervous System Disease Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Antidepressants
- Antipsychotics
- Anti-Dementia Drugs
- Anti-Parkinson's Drugs
- Antiepileptic Drugs
- Others
- Hospital and Clinic
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Biogen
- Otsuka
- Novartis
- Teva Pharmaceutical
- Johnson & Johnson
- AstraZeneca
- Merck
- GSK
- Eli Lilly and Company
- Lundbeck
- Takeda
- Bristol Myers Squibb
- Jiangsu Nhwa Pharmaceutical
- Luye Pharma
- Zhejiang Huahai Pharmaceutical
- Chengdu Easton Biopharmaceuticals
- Hansoh Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Central Nervous System Disease Drugs Market Size (2021-2032)
2.1.2 Central Nervous System Disease Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Central Nervous System Disease Drugs by Country/Region (2021, 2025 & 2032)
2.2 Central Nervous System Disease Drugs Segment by Type
2.2.1 Antidepressants
2.2.2 Antipsychotics
2.2.3 Anti-Dementia Drugs
2.2.4 Anti-Parkinson's Drugs
2.2.5 Antiepileptic Drugs
2.2.6 Others
2.2.7 Central Nervous System Disease Drugs Market Size by Type
2.2.7.1 Central Nervous System Disease Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.7.2 Global Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
2.3 Central Nervous System Disease Drugs Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Central Nervous System Disease Drugs Market Size by Application
2.3.3.1 Central Nervous System Disease Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
3 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET SIZE BY PLAYER
3.1 Central Nervous System Disease Drugs Market Size Market Share by Player
3.1.1 Global Central Nervous System Disease Drugs Revenue by Player (2021-2026)
3.1.2 Global Central Nervous System Disease Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Central Nervous System Disease Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CENTRAL NERVOUS SYSTEM DISEASE DRUGS BY REGION
4.1 Central Nervous System Disease Drugs Market Size by Region (2021-2026)
4.2 Global Central Nervous System Disease Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Central Nervous System Disease Drugs Market Size Growth (2021-2026)
4.4 APAC Central Nervous System Disease Drugs Market Size Growth (2021-2026)
4.5 Europe Central Nervous System Disease Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Central Nervous System Disease Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Central Nervous System Disease Drugs Market Size by Country (2021-2026)
5.2 Americas Central Nervous System Disease Drugs Market Size by Type (2021-2026)
5.3 Americas Central Nervous System Disease Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Central Nervous System Disease Drugs Market Size by Region (2021-2026)
6.2 APAC Central Nervous System Disease Drugs Market Size by Type (2021-2026)
6.3 APAC Central Nervous System Disease Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Central Nervous System Disease Drugs Market Size by Country (2021-2026)
7.2 Europe Central Nervous System Disease Drugs Market Size by Type (2021-2026)
7.3 Europe Central Nervous System Disease Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Central Nervous System Disease Drugs by Region (2021-2026)
8.2 Middle East & Africa Central Nervous System Disease Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Central Nervous System Disease Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET FORECAST
10.1 Global Central Nervous System Disease Drugs Forecast by Region (2027-2032)
10.1.1 Global Central Nervous System Disease Drugs Forecast by Region (2027-2032)
10.1.2 Americas Central Nervous System Disease Drugs Forecast
10.1.3 APAC Central Nervous System Disease Drugs Forecast
10.1.4 Europe Central Nervous System Disease Drugs Forecast
10.1.5 Middle East & Africa Central Nervous System Disease Drugs Forecast
10.2 Americas Central Nervous System Disease Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Central Nervous System Disease Drugs Forecast
10.2.2 Canada Market Central Nervous System Disease Drugs Forecast
10.2.3 Mexico Market Central Nervous System Disease Drugs Forecast
10.2.4 Brazil Market Central Nervous System Disease Drugs Forecast
10.3 APAC Central Nervous System Disease Drugs Forecast by Region (2027-2032)
10.3.1 China Central Nervous System Disease Drugs Market Forecast
10.3.2 Japan Market Central Nervous System Disease Drugs Forecast
10.3.3 Korea Market Central Nervous System Disease Drugs Forecast
10.3.4 Southeast Asia Market Central Nervous System Disease Drugs Forecast
10.3.5 India Market Central Nervous System Disease Drugs Forecast
10.3.6 Australia Market Central Nervous System Disease Drugs Forecast
10.4 Europe Central Nervous System Disease Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Central Nervous System Disease Drugs Forecast
10.4.2 France Market Central Nervous System Disease Drugs Forecast
10.4.3 UK Market Central Nervous System Disease Drugs Forecast
10.4.4 Italy Market Central Nervous System Disease Drugs Forecast
10.4.5 Russia Market Central Nervous System Disease Drugs Forecast
10.5 Middle East & Africa Central Nervous System Disease Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Central Nervous System Disease Drugs Forecast
10.5.2 South Africa Market Central Nervous System Disease Drugs Forecast
10.5.3 Israel Market Central Nervous System Disease Drugs Forecast
10.5.4 Turkey Market Central Nervous System Disease Drugs Forecast
10.6 Global Central Nervous System Disease Drugs Forecast by Type (2027-2032)
10.7 Global Central Nervous System Disease Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Central Nervous System Disease Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Central Nervous System Disease Drugs Product Offered
11.1.3 Pfizer Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Central Nervous System Disease Drugs Product Offered
11.2.3 Biogen Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Otsuka
11.3.1 Otsuka Company Information
11.3.2 Otsuka Central Nervous System Disease Drugs Product Offered
11.3.3 Otsuka Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Otsuka Main Business Overview
11.3.5 Otsuka Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Central Nervous System Disease Drugs Product Offered
11.4.3 Novartis Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Information
11.5.2 Teva Pharmaceutical Central Nervous System Disease Drugs Product Offered
11.5.3 Teva Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Teva Pharmaceutical Main Business Overview
11.5.5 Teva Pharmaceutical Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Central Nervous System Disease Drugs Product Offered
11.6.3 Johnson & Johnson Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Central Nervous System Disease Drugs Product Offered
11.7.3 AstraZeneca Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Central Nervous System Disease Drugs Product Offered
11.8.3 Merck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 GSK
11.9.1 GSK Company Information
11.9.2 GSK Central Nervous System Disease Drugs Product Offered
11.9.3 GSK Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 GSK Main Business Overview
11.9.5 GSK Latest Developments
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Information
11.10.2 Eli Lilly and Company Central Nervous System Disease Drugs Product Offered
11.10.3 Eli Lilly and Company Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Eli Lilly and Company Main Business Overview
11.10.5 Eli Lilly and Company Latest Developments
11.11 Lundbeck
11.11.1 Lundbeck Company Information
11.11.2 Lundbeck Central Nervous System Disease Drugs Product Offered
11.11.3 Lundbeck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Lundbeck Main Business Overview
11.11.5 Lundbeck Latest Developments
11.12 Takeda
11.12.1 Takeda Company Information
11.12.2 Takeda Central Nervous System Disease Drugs Product Offered
11.12.3 Takeda Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Takeda Main Business Overview
11.12.5 Takeda Latest Developments
11.13 Bristol Myers Squibb
11.13.1 Bristol Myers Squibb Company Information
11.13.2 Bristol Myers Squibb Central Nervous System Disease Drugs Product Offered
11.13.3 Bristol Myers Squibb Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Bristol Myers Squibb Main Business Overview
11.13.5 Bristol Myers Squibb Latest Developments
11.14 Jiangsu Nhwa Pharmaceutical
11.14.1 Jiangsu Nhwa Pharmaceutical Company Information
11.14.2 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Offered
11.14.3 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
11.14.5 Jiangsu Nhwa Pharmaceutical Latest Developments
11.15 Luye Pharma
11.15.1 Luye Pharma Company Information
11.15.2 Luye Pharma Central Nervous System Disease Drugs Product Offered
11.15.3 Luye Pharma Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Luye Pharma Main Business Overview
11.15.5 Luye Pharma Latest Developments
11.16 Zhejiang Huahai Pharmaceutical
11.16.1 Zhejiang Huahai Pharmaceutical Company Information
11.16.2 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Offered
11.16.3 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Zhejiang Huahai Pharmaceutical Main Business Overview
11.16.5 Zhejiang Huahai Pharmaceutical Latest Developments
11.17 Chengdu Easton Biopharmaceuticals
11.17.1 Chengdu Easton Biopharmaceuticals Company Information
11.17.2 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Offered
11.17.3 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Chengdu Easton Biopharmaceuticals Main Business Overview
11.17.5 Chengdu Easton Biopharmaceuticals Latest Developments
11.18 Hansoh Pharmaceutical
11.18.1 Hansoh Pharmaceutical Company Information
11.18.2 Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Offered
11.18.3 Hansoh Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Hansoh Pharmaceutical Main Business Overview
11.18.5 Hansoh Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Central Nervous System Disease Drugs Market Size (2021-2032)
2.1.2 Central Nervous System Disease Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Central Nervous System Disease Drugs by Country/Region (2021, 2025 & 2032)
2.2 Central Nervous System Disease Drugs Segment by Type
2.2.1 Antidepressants
2.2.2 Antipsychotics
2.2.3 Anti-Dementia Drugs
2.2.4 Anti-Parkinson's Drugs
2.2.5 Antiepileptic Drugs
2.2.6 Others
2.2.7 Central Nervous System Disease Drugs Market Size by Type
2.2.7.1 Central Nervous System Disease Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.7.2 Global Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
2.3 Central Nervous System Disease Drugs Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Central Nervous System Disease Drugs Market Size by Application
2.3.3.1 Central Nervous System Disease Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
3 CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET SIZE BY PLAYER
3.1 Central Nervous System Disease Drugs Market Size Market Share by Player
3.1.1 Global Central Nervous System Disease Drugs Revenue by Player (2021-2026)
3.1.2 Global Central Nervous System Disease Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Central Nervous System Disease Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CENTRAL NERVOUS SYSTEM DISEASE DRUGS BY REGION
4.1 Central Nervous System Disease Drugs Market Size by Region (2021-2026)
4.2 Global Central Nervous System Disease Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Central Nervous System Disease Drugs Market Size Growth (2021-2026)
4.4 APAC Central Nervous System Disease Drugs Market Size Growth (2021-2026)
4.5 Europe Central Nervous System Disease Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Central Nervous System Disease Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Central Nervous System Disease Drugs Market Size by Country (2021-2026)
5.2 Americas Central Nervous System Disease Drugs Market Size by Type (2021-2026)
5.3 Americas Central Nervous System Disease Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Central Nervous System Disease Drugs Market Size by Region (2021-2026)
6.2 APAC Central Nervous System Disease Drugs Market Size by Type (2021-2026)
6.3 APAC Central Nervous System Disease Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Central Nervous System Disease Drugs Market Size by Country (2021-2026)
7.2 Europe Central Nervous System Disease Drugs Market Size by Type (2021-2026)
7.3 Europe Central Nervous System Disease Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Central Nervous System Disease Drugs by Region (2021-2026)
8.2 Middle East & Africa Central Nervous System Disease Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Central Nervous System Disease Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CENTRAL NERVOUS SYSTEM DISEASE DRUGS MARKET FORECAST
10.1 Global Central Nervous System Disease Drugs Forecast by Region (2027-2032)
10.1.1 Global Central Nervous System Disease Drugs Forecast by Region (2027-2032)
10.1.2 Americas Central Nervous System Disease Drugs Forecast
10.1.3 APAC Central Nervous System Disease Drugs Forecast
10.1.4 Europe Central Nervous System Disease Drugs Forecast
10.1.5 Middle East & Africa Central Nervous System Disease Drugs Forecast
10.2 Americas Central Nervous System Disease Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Central Nervous System Disease Drugs Forecast
10.2.2 Canada Market Central Nervous System Disease Drugs Forecast
10.2.3 Mexico Market Central Nervous System Disease Drugs Forecast
10.2.4 Brazil Market Central Nervous System Disease Drugs Forecast
10.3 APAC Central Nervous System Disease Drugs Forecast by Region (2027-2032)
10.3.1 China Central Nervous System Disease Drugs Market Forecast
10.3.2 Japan Market Central Nervous System Disease Drugs Forecast
10.3.3 Korea Market Central Nervous System Disease Drugs Forecast
10.3.4 Southeast Asia Market Central Nervous System Disease Drugs Forecast
10.3.5 India Market Central Nervous System Disease Drugs Forecast
10.3.6 Australia Market Central Nervous System Disease Drugs Forecast
10.4 Europe Central Nervous System Disease Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Central Nervous System Disease Drugs Forecast
10.4.2 France Market Central Nervous System Disease Drugs Forecast
10.4.3 UK Market Central Nervous System Disease Drugs Forecast
10.4.4 Italy Market Central Nervous System Disease Drugs Forecast
10.4.5 Russia Market Central Nervous System Disease Drugs Forecast
10.5 Middle East & Africa Central Nervous System Disease Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Central Nervous System Disease Drugs Forecast
10.5.2 South Africa Market Central Nervous System Disease Drugs Forecast
10.5.3 Israel Market Central Nervous System Disease Drugs Forecast
10.5.4 Turkey Market Central Nervous System Disease Drugs Forecast
10.6 Global Central Nervous System Disease Drugs Forecast by Type (2027-2032)
10.7 Global Central Nervous System Disease Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Central Nervous System Disease Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Central Nervous System Disease Drugs Product Offered
11.1.3 Pfizer Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Central Nervous System Disease Drugs Product Offered
11.2.3 Biogen Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Otsuka
11.3.1 Otsuka Company Information
11.3.2 Otsuka Central Nervous System Disease Drugs Product Offered
11.3.3 Otsuka Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Otsuka Main Business Overview
11.3.5 Otsuka Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Central Nervous System Disease Drugs Product Offered
11.4.3 Novartis Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Information
11.5.2 Teva Pharmaceutical Central Nervous System Disease Drugs Product Offered
11.5.3 Teva Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Teva Pharmaceutical Main Business Overview
11.5.5 Teva Pharmaceutical Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Central Nervous System Disease Drugs Product Offered
11.6.3 Johnson & Johnson Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Central Nervous System Disease Drugs Product Offered
11.7.3 AstraZeneca Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Central Nervous System Disease Drugs Product Offered
11.8.3 Merck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 GSK
11.9.1 GSK Company Information
11.9.2 GSK Central Nervous System Disease Drugs Product Offered
11.9.3 GSK Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 GSK Main Business Overview
11.9.5 GSK Latest Developments
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Information
11.10.2 Eli Lilly and Company Central Nervous System Disease Drugs Product Offered
11.10.3 Eli Lilly and Company Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Eli Lilly and Company Main Business Overview
11.10.5 Eli Lilly and Company Latest Developments
11.11 Lundbeck
11.11.1 Lundbeck Company Information
11.11.2 Lundbeck Central Nervous System Disease Drugs Product Offered
11.11.3 Lundbeck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Lundbeck Main Business Overview
11.11.5 Lundbeck Latest Developments
11.12 Takeda
11.12.1 Takeda Company Information
11.12.2 Takeda Central Nervous System Disease Drugs Product Offered
11.12.3 Takeda Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Takeda Main Business Overview
11.12.5 Takeda Latest Developments
11.13 Bristol Myers Squibb
11.13.1 Bristol Myers Squibb Company Information
11.13.2 Bristol Myers Squibb Central Nervous System Disease Drugs Product Offered
11.13.3 Bristol Myers Squibb Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Bristol Myers Squibb Main Business Overview
11.13.5 Bristol Myers Squibb Latest Developments
11.14 Jiangsu Nhwa Pharmaceutical
11.14.1 Jiangsu Nhwa Pharmaceutical Company Information
11.14.2 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Offered
11.14.3 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
11.14.5 Jiangsu Nhwa Pharmaceutical Latest Developments
11.15 Luye Pharma
11.15.1 Luye Pharma Company Information
11.15.2 Luye Pharma Central Nervous System Disease Drugs Product Offered
11.15.3 Luye Pharma Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Luye Pharma Main Business Overview
11.15.5 Luye Pharma Latest Developments
11.16 Zhejiang Huahai Pharmaceutical
11.16.1 Zhejiang Huahai Pharmaceutical Company Information
11.16.2 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Offered
11.16.3 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Zhejiang Huahai Pharmaceutical Main Business Overview
11.16.5 Zhejiang Huahai Pharmaceutical Latest Developments
11.17 Chengdu Easton Biopharmaceuticals
11.17.1 Chengdu Easton Biopharmaceuticals Company Information
11.17.2 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Offered
11.17.3 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Chengdu Easton Biopharmaceuticals Main Business Overview
11.17.5 Chengdu Easton Biopharmaceuticals Latest Developments
11.18 Hansoh Pharmaceutical
11.18.1 Hansoh Pharmaceutical Company Information
11.18.2 Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Offered
11.18.3 Hansoh Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Hansoh Pharmaceutical Main Business Overview
11.18.5 Hansoh Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Central Nervous System Disease Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Central Nervous System Disease Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antidepressants
Table 4. Major Players of Antipsychotics
Table 5. Major Players of Anti-Dementia Drugs
Table 6. Major Players of Anti-Parkinson's Drugs
Table 7. Major Players of Antiepileptic Drugs
Table 8. Major Players of Others
Table 9. Central Nervous System Disease Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 11. Global Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Table 12. Central Nervous System Disease Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 14. Global Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Table 15. Global Central Nervous System Disease Drugs Revenue by Player (2021-2026) & ($ millions)
Table 16. Global Central Nervous System Disease Drugs Revenue Market Share by Player (2021-2026)
Table 17. Central Nervous System Disease Drugs Key Players Head office and Products Offered
Table 18. Central Nervous System Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Central Nervous System Disease Drugs Market Size by Region (2021-2026) & ($ millions)
Table 22. Global Central Nervous System Disease Drugs Market Size Market Share by Region (2021-2026)
Table 23. Global Central Nervous System Disease Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 24. Global Central Nervous System Disease Drugs Revenue Market Share by Country/Region (2021-2026)
Table 25. Americas Central Nervous System Disease Drugs Market Size by Country (2021-2026) & ($ millions)
Table 26. Americas Central Nervous System Disease Drugs Market Size Market Share by Country (2021-2026)
Table 27. Americas Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 28. Americas Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Table 29. Americas Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 30. Americas Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Table 31. APAC Central Nervous System Disease Drugs Market Size by Region (2021-2026) & ($ millions)
Table 32. APAC Central Nervous System Disease Drugs Market Size Market Share by Region (2021-2026)
Table 33. APAC Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 34. APAC Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 35. Europe Central Nervous System Disease Drugs Market Size by Country (2021-2026) & ($ millions)
Table 36. Europe Central Nervous System Disease Drugs Market Size Market Share by Country (2021-2026)
Table 37. Europe Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 38. Europe Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 39. Middle East & Africa Central Nervous System Disease Drugs Market Size by Region (2021-2026) & ($ millions)
Table 40. Middle East & Africa Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 41. Middle East & Africa Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Central Nervous System Disease Drugs
Table 43. Key Market Challenges & Risks of Central Nervous System Disease Drugs
Table 44. Key Industry Trends of Central Nervous System Disease Drugs
Table 45. Global Central Nervous System Disease Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 46. Global Central Nervous System Disease Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 47. Global Central Nervous System Disease Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 48. Global Central Nervous System Disease Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 49. Pfizer Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 50. Pfizer Central Nervous System Disease Drugs Product Offered
Table 51. Pfizer Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 52. Pfizer Main Business
Table 53. Pfizer Latest Developments
Table 54. Biogen Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 55. Biogen Central Nervous System Disease Drugs Product Offered
Table 56. Biogen Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 57. Biogen Main Business
Table 58. Biogen Latest Developments
Table 59. Otsuka Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 60. Otsuka Central Nervous System Disease Drugs Product Offered
Table 61. Otsuka Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Otsuka Main Business
Table 63. Otsuka Latest Developments
Table 64. Novartis Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 65. Novartis Central Nervous System Disease Drugs Product Offered
Table 66. Novartis Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Novartis Main Business
Table 68. Novartis Latest Developments
Table 69. Teva Pharmaceutical Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 70. Teva Pharmaceutical Central Nervous System Disease Drugs Product Offered
Table 71. Teva Pharmaceutical Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Teva Pharmaceutical Main Business
Table 73. Teva Pharmaceutical Latest Developments
Table 74. Johnson & Johnson Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 75. Johnson & Johnson Central Nervous System Disease Drugs Product Offered
Table 76. Johnson & Johnson Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Latest Developments
Table 79. AstraZeneca Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 80. AstraZeneca Central Nervous System Disease Drugs Product Offered
Table 81. AstraZeneca Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. AstraZeneca Main Business
Table 83. AstraZeneca Latest Developments
Table 84. Merck Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 85. Merck Central Nervous System Disease Drugs Product Offered
Table 86. Merck Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. GSK Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 90. GSK Central Nervous System Disease Drugs Product Offered
Table 91. GSK Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. GSK Main Business
Table 93. GSK Latest Developments
Table 94. Eli Lilly and Company Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 95. Eli Lilly and Company Central Nervous System Disease Drugs Product Offered
Table 96. Eli Lilly and Company Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Eli Lilly and Company Main Business
Table 98. Eli Lilly and Company Latest Developments
Table 99. Lundbeck Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 100. Lundbeck Central Nervous System Disease Drugs Product Offered
Table 101. Lundbeck Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Lundbeck Main Business
Table 103. Lundbeck Latest Developments
Table 104. Takeda Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 105. Takeda Central Nervous System Disease Drugs Product Offered
Table 106. Takeda Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Takeda Main Business
Table 108. Takeda Latest Developments
Table 109. Bristol Myers Squibb Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 110. Bristol Myers Squibb Central Nervous System Disease Drugs Product Offered
Table 111. Bristol Myers Squibb Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Bristol Myers Squibb Main Business
Table 113. Bristol Myers Squibb Latest Developments
Table 114. Jiangsu Nhwa Pharmaceutical Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 115. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Offered
Table 116. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Jiangsu Nhwa Pharmaceutical Main Business
Table 118. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 119. Luye Pharma Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 120. Luye Pharma Central Nervous System Disease Drugs Product Offered
Table 121. Luye Pharma Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Luye Pharma Main Business
Table 123. Luye Pharma Latest Developments
Table 124. Zhejiang Huahai Pharmaceutical Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 125. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Offered
Table 126. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Zhejiang Huahai Pharmaceutical Main Business
Table 128. Zhejiang Huahai Pharmaceutical Latest Developments
Table 129. Chengdu Easton Biopharmaceuticals Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 130. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Offered
Table 131. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Chengdu Easton Biopharmaceuticals Main Business
Table 133. Chengdu Easton Biopharmaceuticals Latest Developments
Table 134. Hansoh Pharmaceutical Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 135. Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Offered
Table 136. Hansoh Pharmaceutical Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Hansoh Pharmaceutical Main Business
Table 138. Hansoh Pharmaceutical Latest Developments
Table 1. Central Nervous System Disease Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Central Nervous System Disease Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antidepressants
Table 4. Major Players of Antipsychotics
Table 5. Major Players of Anti-Dementia Drugs
Table 6. Major Players of Anti-Parkinson's Drugs
Table 7. Major Players of Antiepileptic Drugs
Table 8. Major Players of Others
Table 9. Central Nervous System Disease Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 11. Global Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Table 12. Central Nervous System Disease Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 14. Global Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Table 15. Global Central Nervous System Disease Drugs Revenue by Player (2021-2026) & ($ millions)
Table 16. Global Central Nervous System Disease Drugs Revenue Market Share by Player (2021-2026)
Table 17. Central Nervous System Disease Drugs Key Players Head office and Products Offered
Table 18. Central Nervous System Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Central Nervous System Disease Drugs Market Size by Region (2021-2026) & ($ millions)
Table 22. Global Central Nervous System Disease Drugs Market Size Market Share by Region (2021-2026)
Table 23. Global Central Nervous System Disease Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 24. Global Central Nervous System Disease Drugs Revenue Market Share by Country/Region (2021-2026)
Table 25. Americas Central Nervous System Disease Drugs Market Size by Country (2021-2026) & ($ millions)
Table 26. Americas Central Nervous System Disease Drugs Market Size Market Share by Country (2021-2026)
Table 27. Americas Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 28. Americas Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Table 29. Americas Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 30. Americas Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Table 31. APAC Central Nervous System Disease Drugs Market Size by Region (2021-2026) & ($ millions)
Table 32. APAC Central Nervous System Disease Drugs Market Size Market Share by Region (2021-2026)
Table 33. APAC Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 34. APAC Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 35. Europe Central Nervous System Disease Drugs Market Size by Country (2021-2026) & ($ millions)
Table 36. Europe Central Nervous System Disease Drugs Market Size Market Share by Country (2021-2026)
Table 37. Europe Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 38. Europe Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 39. Middle East & Africa Central Nervous System Disease Drugs Market Size by Region (2021-2026) & ($ millions)
Table 40. Middle East & Africa Central Nervous System Disease Drugs Market Size by Type (2021-2026) & ($ millions)
Table 41. Middle East & Africa Central Nervous System Disease Drugs Market Size by Application (2021-2026) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Central Nervous System Disease Drugs
Table 43. Key Market Challenges & Risks of Central Nervous System Disease Drugs
Table 44. Key Industry Trends of Central Nervous System Disease Drugs
Table 45. Global Central Nervous System Disease Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 46. Global Central Nervous System Disease Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 47. Global Central Nervous System Disease Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 48. Global Central Nervous System Disease Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 49. Pfizer Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 50. Pfizer Central Nervous System Disease Drugs Product Offered
Table 51. Pfizer Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 52. Pfizer Main Business
Table 53. Pfizer Latest Developments
Table 54. Biogen Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 55. Biogen Central Nervous System Disease Drugs Product Offered
Table 56. Biogen Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 57. Biogen Main Business
Table 58. Biogen Latest Developments
Table 59. Otsuka Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 60. Otsuka Central Nervous System Disease Drugs Product Offered
Table 61. Otsuka Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Otsuka Main Business
Table 63. Otsuka Latest Developments
Table 64. Novartis Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 65. Novartis Central Nervous System Disease Drugs Product Offered
Table 66. Novartis Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Novartis Main Business
Table 68. Novartis Latest Developments
Table 69. Teva Pharmaceutical Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 70. Teva Pharmaceutical Central Nervous System Disease Drugs Product Offered
Table 71. Teva Pharmaceutical Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Teva Pharmaceutical Main Business
Table 73. Teva Pharmaceutical Latest Developments
Table 74. Johnson & Johnson Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 75. Johnson & Johnson Central Nervous System Disease Drugs Product Offered
Table 76. Johnson & Johnson Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Latest Developments
Table 79. AstraZeneca Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 80. AstraZeneca Central Nervous System Disease Drugs Product Offered
Table 81. AstraZeneca Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. AstraZeneca Main Business
Table 83. AstraZeneca Latest Developments
Table 84. Merck Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 85. Merck Central Nervous System Disease Drugs Product Offered
Table 86. Merck Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. GSK Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 90. GSK Central Nervous System Disease Drugs Product Offered
Table 91. GSK Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. GSK Main Business
Table 93. GSK Latest Developments
Table 94. Eli Lilly and Company Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 95. Eli Lilly and Company Central Nervous System Disease Drugs Product Offered
Table 96. Eli Lilly and Company Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Eli Lilly and Company Main Business
Table 98. Eli Lilly and Company Latest Developments
Table 99. Lundbeck Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 100. Lundbeck Central Nervous System Disease Drugs Product Offered
Table 101. Lundbeck Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Lundbeck Main Business
Table 103. Lundbeck Latest Developments
Table 104. Takeda Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 105. Takeda Central Nervous System Disease Drugs Product Offered
Table 106. Takeda Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Takeda Main Business
Table 108. Takeda Latest Developments
Table 109. Bristol Myers Squibb Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 110. Bristol Myers Squibb Central Nervous System Disease Drugs Product Offered
Table 111. Bristol Myers Squibb Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Bristol Myers Squibb Main Business
Table 113. Bristol Myers Squibb Latest Developments
Table 114. Jiangsu Nhwa Pharmaceutical Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 115. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product Offered
Table 116. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Jiangsu Nhwa Pharmaceutical Main Business
Table 118. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 119. Luye Pharma Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 120. Luye Pharma Central Nervous System Disease Drugs Product Offered
Table 121. Luye Pharma Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Luye Pharma Main Business
Table 123. Luye Pharma Latest Developments
Table 124. Zhejiang Huahai Pharmaceutical Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 125. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product Offered
Table 126. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Zhejiang Huahai Pharmaceutical Main Business
Table 128. Zhejiang Huahai Pharmaceutical Latest Developments
Table 129. Chengdu Easton Biopharmaceuticals Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 130. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product Offered
Table 131. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Chengdu Easton Biopharmaceuticals Main Business
Table 133. Chengdu Easton Biopharmaceuticals Latest Developments
Table 134. Hansoh Pharmaceutical Details, Company Type, Central Nervous System Disease Drugs Area Served and Its Competitors
Table 135. Hansoh Pharmaceutical Central Nervous System Disease Drugs Product Offered
Table 136. Hansoh Pharmaceutical Central Nervous System Disease Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Hansoh Pharmaceutical Main Business
Table 138. Hansoh Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Central Nervous System Disease Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Central Nervous System Disease Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Central Nervous System Disease Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Central Nervous System Disease Drugs Sales Market Share by Country/Region (2025)
Figure 8. Central Nervous System Disease Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Central Nervous System Disease Drugs Market Size Market Share by Type in 2025
Figure 10. Central Nervous System Disease Drugs in Hospital and Clinic
Figure 11. Global Central Nervous System Disease Drugs Market: Hospital and Clinic (2021-2026) & ($ millions)
Figure 12. Central Nervous System Disease Drugs in Pharmacy
Figure 13. Global Central Nervous System Disease Drugs Market: Pharmacy (2021-2026) & ($ millions)
Figure 14. Global Central Nervous System Disease Drugs Market Size Market Share by Application in 2025
Figure 15. Global Central Nervous System Disease Drugs Revenue Market Share by Player in 2025
Figure 16. Global Central Nervous System Disease Drugs Market Size Market Share by Region (2021-2026)
Figure 17. Americas Central Nervous System Disease Drugs Market Size 2021-2026 ($ millions)
Figure 18. APAC Central Nervous System Disease Drugs Market Size 2021-2026 ($ millions)
Figure 19. Europe Central Nervous System Disease Drugs Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Central Nervous System Disease Drugs Market Size 2021-2026 ($ millions)
Figure 21. Americas Central Nervous System Disease Drugs Value Market Share by Country in 2025
Figure 22. United States Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Central Nervous System Disease Drugs Market Size Market Share by Region in 2025
Figure 27. APAC Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Figure 28. APAC Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Figure 29. China Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. India Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Central Nervous System Disease Drugs Market Size Market Share by Country in 2025
Figure 36. Europe Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Figure 37. Europe Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Figure 38. Germany Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 39. France Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Central Nervous System Disease Drugs Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 52. APAC Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 53. Europe Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 55. United States Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 56. Canada Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 57. Mexico Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 58. Brazil Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 59. China Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 60. Japan Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 61. Korea Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 63. India Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 64. Australia Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 65. Germany Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 66. France Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 67. UK Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 68. Italy Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 69. Russia Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 70. Egypt Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 71. South Africa Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 72. Israel Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 73. Turkey Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 74. Global Central Nervous System Disease Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Central Nervous System Disease Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 1. Central Nervous System Disease Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Central Nervous System Disease Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Central Nervous System Disease Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Central Nervous System Disease Drugs Sales Market Share by Country/Region (2025)
Figure 8. Central Nervous System Disease Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Central Nervous System Disease Drugs Market Size Market Share by Type in 2025
Figure 10. Central Nervous System Disease Drugs in Hospital and Clinic
Figure 11. Global Central Nervous System Disease Drugs Market: Hospital and Clinic (2021-2026) & ($ millions)
Figure 12. Central Nervous System Disease Drugs in Pharmacy
Figure 13. Global Central Nervous System Disease Drugs Market: Pharmacy (2021-2026) & ($ millions)
Figure 14. Global Central Nervous System Disease Drugs Market Size Market Share by Application in 2025
Figure 15. Global Central Nervous System Disease Drugs Revenue Market Share by Player in 2025
Figure 16. Global Central Nervous System Disease Drugs Market Size Market Share by Region (2021-2026)
Figure 17. Americas Central Nervous System Disease Drugs Market Size 2021-2026 ($ millions)
Figure 18. APAC Central Nervous System Disease Drugs Market Size 2021-2026 ($ millions)
Figure 19. Europe Central Nervous System Disease Drugs Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Central Nervous System Disease Drugs Market Size 2021-2026 ($ millions)
Figure 21. Americas Central Nervous System Disease Drugs Value Market Share by Country in 2025
Figure 22. United States Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Central Nervous System Disease Drugs Market Size Market Share by Region in 2025
Figure 27. APAC Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Figure 28. APAC Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Figure 29. China Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. India Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Central Nervous System Disease Drugs Market Size Market Share by Country in 2025
Figure 36. Europe Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Figure 37. Europe Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Figure 38. Germany Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 39. France Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Central Nervous System Disease Drugs Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Central Nervous System Disease Drugs Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Central Nervous System Disease Drugs Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Central Nervous System Disease Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 52. APAC Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 53. Europe Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 55. United States Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 56. Canada Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 57. Mexico Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 58. Brazil Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 59. China Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 60. Japan Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 61. Korea Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 63. India Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 64. Australia Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 65. Germany Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 66. France Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 67. UK Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 68. Italy Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 69. Russia Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 70. Egypt Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 71. South Africa Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 72. Israel Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 73. Turkey Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
Figure 74. Global Central Nervous System Disease Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Central Nervous System Disease Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Central Nervous System Disease Drugs Market Size 2027-2032 ($ millions)
